{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,980.00",
    "chg": 58.7,
    "chgp": "3.06%",
    "dir": 1,
    "prev_price": "1,921.30",
    "mcapval": "90,399.88 Cr",
    "mcap": "Large Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE326A01037",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:09 AM",
    "bse_nse_vol": "6.22 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd. Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-22-45-surge-in-open-interest-reaching-29096-contracts-1700452",
        "imagepath": "",
        "date": "2025-04-03 15:00:14",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today, reflecting heightened trading activity. The latest open interest stands at 29,096 contracts, up from the previous 23,761, marking a change of 5,335 contracts or a 22.45% increase. The trading volume for the day reached 68,119 contracts, indicating robust market engagement.\n\nIn terms of price performance, Lupin's stock opened with a notable gain of 4.49% and achieved an intraday high of Rs 2,150, representing a 6.98% increase. Over the past two days, the stock has shown a cumulative return of 6.7%, outperforming its sector by 1.83%. Additionally, the stock is currently trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average.\n\nThe Pharmaceuticals & Drugs sector overall has gained by 2.15%, while Lupin's liquidity..."
      },
      {
        "title": "Lupin Ltd. Sees Significant Surge in Open Interest Amid Increased Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-22-45-surge-in-open-interest-to-29096-contracts-1699330",
        "imagepath": "",
        "date": "2025-04-03 14:00:16",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 29,096 contracts, reflecting a rise of 5,335 contracts or 22.45% from the previous open interest of 23,761. The trading volume for the day reached 68,119 contracts, indicating robust activity in the market.\n\nIn terms of price performance, Lupin has outperformed its sector by 1.93%, with the stock gaining 7.04% over the last two days. Today, it opened with a notable gain of 4.49%, reaching an intraday high of Rs 2,150, which represents a 6.98% increase. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend.\n\nAdditionally, the Pharmaceuticals & Drugs sector has seen a gain of 2.22%, while Lupin's delivery volume on April 2 has surged by 68.88% compared to its 5-day..."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-20-41-surge-in-open-interest-amid-increased-trading-activity-1698223",
        "imagepath": "",
        "date": "2025-04-03 13:00:13",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 28,610 contracts, reflecting a rise of 4,849 contracts or 20.41% from the previous open interest of 23,761. This surge coincides with a trading volume of 62,569 contracts, indicating heightened activity in the stock.\n\nIn terms of price performance, Lupin has outperformed its sector by 1.8%, with the stock gaining 6.96% over the last two days. Today, it opened with a notable gain of 4.49%, reaching an intraday high of Rs 2,150, which represents a 6.98% increase. The stock is currently trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average.\n\nAdditionally, the Pharmaceuticals & Drugs sector has seen a gain of 2.23%. Notably, the delivery volume for Lupin on April 2 has surged by..."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-20-41-surge-in-open-interest-reaching-28610-contracts-1696940",
        "imagepath": "",
        "date": "2025-04-03 12:00:15",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 28,610 contracts, reflecting a rise of 4,849 contracts or 20.41% from the previous open interest of 23,761. This surge in open interest coincides with a trading volume of 62,569 contracts, indicating heightened activity in the stock.\n\nIn terms of price performance, Lupin has outperformed its sector by 2%, with a notable gain of 4.40% on the day. The stock opened with a gain of 4.49% and reached an intraday high of Rs 2,150, marking a 6.98% increase. Over the past two days, Lupin has shown a consistent upward trend, accumulating a total return of 7.39%.\n\nAdditionally, the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong performance relative to these benchmarks. The Pharmaceut..."
      },
      {
        "title": "Lupin Ltd. Sees Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-15-64-surge-in-open-interest-reaching-27477-contracts-1694352",
        "imagepath": "",
        "date": "2025-04-03 10:00:08",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today, reflecting heightened trading activity. The latest open interest stands at 27,477 contracts, up from the previous 23,761, marking a change of 3,716 contracts or a 15.64% increase. The trading volume for the day reached 34,981 contracts, indicating robust market engagement.\n\nIn terms of price performance, Lupin has outperformed its sector by 2.43%, with the stock gaining 9.29% over the last two days. Today, it opened with a notable gain of 4.49%, reaching an intraday high of Rs 2,144.85, which represents a 6.72% increase. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend.\n\nThe Pharmaceuticals & Drugs sector overall has gained 3.59%, while Lupin's liquidity remains favorable, with a delivery vol..."
      },
      {
        "title": "Lupin Ltd. Surges Amid Market Volatility, Outperforming Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-stock-rises-6-24-outperforming-pharmaceuticals-sector-amid-market-volatility-1693263",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/Lupin_priceRelatedfactors_882927.png",
        "date": "2025-04-03 09:30:30",
        "description": "Lupin Ltd. has demonstrated notable performance in the Pharmaceuticals & Drugs sector, gaining 6.24% on April 3, 2025, and outperforming its sector. The stock has shown a total increase of 8.6% over two days, trading above key moving averages amid high volatility in the market."
      },
      {
        "title": "Lupin Ltd. Sees Significant Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-19-33-surge-in-open-interest-to-22318-contracts-1672653",
        "imagepath": "",
        "date": "2025-04-02 10:00:15",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 22,318 contracts, reflecting a rise of 3,615 contracts or 19.33% from the previous open interest of 18,703. This surge in open interest coincides with a trading volume of 19,565 contracts, indicating heightened activity in the stock.\n\nIn terms of performance, Lupin has outperformed its sector by 1.14%, with a one-day return of 0.98%. However, it is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a mixed technical outlook. The stock's underlying value is noted at Rs 1,960, with a total futures value of approximately Rs 35,475.53 lakhs and an options value of around Rs 13,370.46 crore.\n\nAdditionally, the delivery volume has seen a notable increase, rising by 34.93% to 6.55 lakh shares on April..."
      },
      {
        "title": "Lupin Faces Mixed Technical Trends Amidst Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupins-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-price-decline-1670543",
        "imagepath": "",
        "date": "2025-04-02 08:05:54",
        "description": "Lupin, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1962.15, down from a previous close of 2026.50. Over the past year, Lupin has experienced a notable return of 20.87%, significantly outperforming the Sensex, which recorded a return of 2.72% in the same period.\n\nIn terms of technical indicators, the weekly MACD and KST are showing bearish signals, while the monthly indicators reflect a mildly bearish trend. The Bollinger Bands indicate a bearish stance on a weekly basis, contrasting with a mildly bullish outlook on a monthly basis. The daily moving averages also suggest a bearish trend, highlighting the stock's current challenges.\n\nLupin's performance over various time frames reveals a mixed picture. While the stock has faced a year-to-date decline of 16.54%, it has shown resi..."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Active Market Participation",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-18-73-surge-in-open-interest-to-22206-contracts-1664037",
        "imagepath": "",
        "date": "2025-04-01 15:00:15",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 22,206 contracts, reflecting a rise of 3,503 contracts or 18.73% from the previous open interest of 18,703. This uptick in open interest comes alongside a trading volume of 16,825 contracts, indicating active market participation.\n\nIn terms of price performance, Lupin's stock has underperformed its sector by 2.39%, with an intraday low of Rs 1,944.05, marking a decline of 4.14%. The weighted average price suggests that more volume was traded closer to this low price point. Additionally, the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.\n\nInvestor participation has also seen a decline, with delivery volume dropping by 10.99% compared to the 5-day average. Despite th..."
      }
    ],
    "total": 163,
    "sid": "641789",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "07-Apr-2025",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Lupin Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24100MH1983PLC029442</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A1+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Amit Kumar Gupta <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: akgupta@lupin.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Ramesh Swaminathan <br/> Designation: Executive Director Global CFO and Head of API Plus SBU <br/> EmailId: rameshswaminathan@lupin.com</div> </div> <div> <br/> Date: 07/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "Certificate under Reg. 74(5) of SEBI (Depositories and Participant) Regulations 2018 for the quarter ended on March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "02-Apr-2025",
      "details": "Lupin Healthcare (UK) Limited a wholly owned subsidiary of the Company has acquired the entire share capital of Renascience Pharma Limited United Kingdom.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>400%</strong> dividend, ex-date: 16 Jul 24",
          "dt": "2024-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lupin Ltd. Sees Surge in Open Interest Amid Increased Trading Activity

2025-04-03 15:00:14

Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today, reflecting heightened trading activity. The latest open interest stands at 29,096 contracts, up from the previous 23,761, marking a change of 5,335 contracts or a 22.45% increase. The trading volume for the day reached 68,119 contracts, indicating robust market engagement. In terms of price performance, Lupin's stock opened with a notable gain of 4.49% and achieved an intraday high of Rs 2,150, representing a 6.98% increase. Over the past two days, the stock has shown a cumulative return of 6.7%, outperforming its sector by 1.83%. Additionally, the stock is currently trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average. The Pharmaceuticals & Drugs sector overall has gained by 2.15%, while Lupin's liquidity...

Read More

Lupin Ltd. Sees Significant Surge in Open Interest Amid Increased Market Activity

2025-04-03 14:00:16

Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 29,096 contracts, reflecting a rise of 5,335 contracts or 22.45% from the previous open interest of 23,761. The trading volume for the day reached 68,119 contracts, indicating robust activity in the market. In terms of price performance, Lupin has outperformed its sector by 1.93%, with the stock gaining 7.04% over the last two days. Today, it opened with a notable gain of 4.49%, reaching an intraday high of Rs 2,150, which represents a 6.98% increase. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend. Additionally, the Pharmaceuticals & Drugs sector has seen a gain of 2.22%, while Lupin's delivery volume on April 2 has surged by 68.88% compared to its 5-day...

Read More

Lupin Ltd. Sees Significant Open Interest Surge Amid Increased Trading Activity

2025-04-03 13:00:13

Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 28,610 contracts, reflecting a rise of 4,849 contracts or 20.41% from the previous open interest of 23,761. This surge coincides with a trading volume of 62,569 contracts, indicating heightened activity in the stock. In terms of price performance, Lupin has outperformed its sector by 1.8%, with the stock gaining 6.96% over the last two days. Today, it opened with a notable gain of 4.49%, reaching an intraday high of Rs 2,150, which represents a 6.98% increase. The stock is currently trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average. Additionally, the Pharmaceuticals & Drugs sector has seen a gain of 2.23%. Notably, the delivery volume for Lupin on April 2 has surged by...

Read More

Lupin Ltd. Sees Significant Open Interest Surge Amid Increased Trading Activity

2025-04-03 12:00:15

Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 28,610 contracts, reflecting a rise of 4,849 contracts or 20.41% from the previous open interest of 23,761. This surge in open interest coincides with a trading volume of 62,569 contracts, indicating heightened activity in the stock. In terms of price performance, Lupin has outperformed its sector by 2%, with a notable gain of 4.40% on the day. The stock opened with a gain of 4.49% and reached an intraday high of Rs 2,150, marking a 6.98% increase. Over the past two days, Lupin has shown a consistent upward trend, accumulating a total return of 7.39%. Additionally, the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong performance relative to these benchmarks. The Pharmaceut...

Read More

Lupin Ltd. Sees Surge in Open Interest Amid Increased Trading Activity

2025-04-03 10:00:08

Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today, reflecting heightened trading activity. The latest open interest stands at 27,477 contracts, up from the previous 23,761, marking a change of 3,716 contracts or a 15.64% increase. The trading volume for the day reached 34,981 contracts, indicating robust market engagement. In terms of price performance, Lupin has outperformed its sector by 2.43%, with the stock gaining 9.29% over the last two days. Today, it opened with a notable gain of 4.49%, reaching an intraday high of Rs 2,144.85, which represents a 6.72% increase. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend. The Pharmaceuticals & Drugs sector overall has gained 3.59%, while Lupin's liquidity remains favorable, with a delivery vol...

Read More

Lupin Ltd. Surges Amid Market Volatility, Outperforming Pharmaceuticals Sector

2025-04-03 09:30:30

Lupin Ltd. has demonstrated notable performance in the Pharmaceuticals & Drugs sector, gaining 6.24% on April 3, 2025, and outperforming its sector. The stock has shown a total increase of 8.6% over two days, trading above key moving averages amid high volatility in the market.

Read More

Lupin Ltd. Sees Significant Surge in Open Interest Amid Increased Trading Activity

2025-04-02 10:00:15

Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 22,318 contracts, reflecting a rise of 3,615 contracts or 19.33% from the previous open interest of 18,703. This surge in open interest coincides with a trading volume of 19,565 contracts, indicating heightened activity in the stock. In terms of performance, Lupin has outperformed its sector by 1.14%, with a one-day return of 0.98%. However, it is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a mixed technical outlook. The stock's underlying value is noted at Rs 1,960, with a total futures value of approximately Rs 35,475.53 lakhs and an options value of around Rs 13,370.46 crore. Additionally, the delivery volume has seen a notable increase, rising by 34.93% to 6.55 lakh shares on April...

Read More

Lupin Faces Mixed Technical Trends Amidst Market Evaluation Revision

2025-04-02 08:05:54

Lupin, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1962.15, down from a previous close of 2026.50. Over the past year, Lupin has experienced a notable return of 20.87%, significantly outperforming the Sensex, which recorded a return of 2.72% in the same period. In terms of technical indicators, the weekly MACD and KST are showing bearish signals, while the monthly indicators reflect a mildly bearish trend. The Bollinger Bands indicate a bearish stance on a weekly basis, contrasting with a mildly bullish outlook on a monthly basis. The daily moving averages also suggest a bearish trend, highlighting the stock's current challenges. Lupin's performance over various time frames reveals a mixed picture. While the stock has faced a year-to-date decline of 16.54%, it has shown resi...

Read More

Lupin Ltd. Sees Significant Open Interest Surge Amid Active Market Participation

2025-04-01 15:00:15

Lupin Ltd., a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 22,206 contracts, reflecting a rise of 3,503 contracts or 18.73% from the previous open interest of 18,703. This uptick in open interest comes alongside a trading volume of 16,825 contracts, indicating active market participation. In terms of price performance, Lupin's stock has underperformed its sector by 2.39%, with an intraday low of Rs 1,944.05, marking a decline of 4.14%. The weighted average price suggests that more volume was traded closer to this low price point. Additionally, the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also seen a decline, with delivery volume dropping by 10.99% compared to the 5-day average. Despite th...

Read More

View All News